Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A commo 둜고

Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A commo (NUVB.WS) μ£Όκ°€ 및 μ’…λͺ© 정보

Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A commo μ‹€μ‹œκ°„ μ£Όκ°€

Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A commo ν˜„μž¬κ°€ 상세 정보
ν•­λͺ© κ°’
ν˜„μž¬κ°€ 0.27 λ‹¬λŸ¬
λ³€λ™λŸ‰ β–² 0.02 λ‹¬λŸ¬
변동λ₯  5.88%
κ±°λž˜λŸ‰ 31,639
κ±°λž˜λŒ€κΈˆ 8,934.854 λ‹¬λŸ¬

Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A commo 일별 μ£Όκ°€

Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A commo의 κ³Όκ±° 일별 μ£Όκ°€
λ‚ μ§œ μ‹œκ°€ κ³ κ°€ μ €κ°€ μ’…κ°€ κ±°λž˜λŸ‰ κ±°λž˜λŒ€κΈˆ
12/23/2025 0.6 0.6 0.256 0.42 108,469 48,127.7
12/24/2025 0.41 0.42 0.41 0.413 710 292.66
12/26/2025 0.413 0.42 0.314 0.335 55,854 19,314.31
12/29/2025 0.213 0.415 0.213 0.321 46,969 17,026.26
12/30/2025 0.339 0.368 0.335 0.335 8,058 2,800.16
12/31/2025 0.33 0.33 0.32 0.33 3,395 1,094.21
1/2/2026 0.32 0.34 0.261 0.31 41,982 13,190.74
1/5/2026 0.281 0.31 0.233 0.28 29,367 8,096.48
1/6/2026 0.238 0.261 0.21 0.255 31,516 7,472.44
1/7/2026 0.28 0.29 0.26 0.27 31,639 8,934.85

Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A commo κΈ°μ—… κ°œμš”

λˆ„λ² μ΄μ…˜ λ°”μ΄μ˜€(Nuvation Bio Inc)λŠ” μ°¨λ³„ν™”λ˜κ³  ν˜μ‹ μ μΈ 치료 후보 λ¬Όμ§ˆμ„ κ°œλ°œν•˜μ—¬ μ’…μ–‘ν•™ λΆ„μ•Όμ˜ λ―ΈμΆ©μ‘± μˆ˜μš”λ₯Ό ν•΄κ²°ν•˜λŠ” 생λͺ…곡학 νšŒμ‚¬μž…λ‹ˆλ‹€. 이 νšŒμ‚¬μ˜ μ œν’ˆ 후보 물질인 νƒˆλ ˆνŠΈλ ‰ν‹°λ‹™μ€ 경ꡬ νˆ¬μ—¬κ°€ κ°€λŠ₯ν•˜κ³ , κ°•λ ₯ν•˜λ©°, 쀑좔신경계에 μž‘μš©ν•˜κ³ , 선택적인 μ°¨μ„ΈλŒ€ c-ros μ’…μ–‘μœ μ „μž 1(ROS1) μ–΅μ œμ œλ‘œ, 특히 ROS1 μ–‘μ„± λΉ„μ†Œμ„Έν¬νμ•”(NSCLC) ν™˜μž 치료λ₯Ό μœ„ν•΄ μ„€κ³„λ˜μ—ˆμŠ΅λ‹ˆλ‹€. λ˜ν•œ, μž„μƒ 단계 νŒŒμ΄ν”„λΌμΈμ—λŠ” μ‚¬ν‘Έμ‹œλ°λ‹™, NUV-1511, NUV-868κ³Ό 같이 개발 단계가 각기 λ‹€λ₯Έ μ°¨λ³„ν™”λ˜κ³  ν˜μ‹ μ μΈ ν•­μ•”μ œ 후보 물질이 ν¬ν•¨λ˜μ–΄ μžˆμŠ΅λ‹ˆλ‹€. 이 νšŒμ‚¬λŠ” 쀑ꡭ과 일본에 μžˆλŠ” 고객과의 ν˜‘λ ₯ 계약을 ν†΅ν•œ λΌμ΄μ„ μŠ€ μ•„μ›ƒμœΌλ‘œ μˆ˜μ΅μ„ μ°½μΆœν•©λ‹ˆλ‹€.

Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A commo AI예츑

AIμ˜ˆμΈ‘κΈ°λŠ” Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A commo을 κ°•λ ₯맀도 Β· 맀도 Β· 쀑립 Β· 맀수 Β· κ°•λ ₯맀수 둜 μ˜ˆμΈ‘ν–ˆμ–΄μš”.

멀버십 ν”Œλžœμ„ κ΅¬λ…ν•˜λ©΄ μ˜ˆμƒ μ£Όκ°€ μ‹œλ‚˜λ¦¬μ˜€μ™€ AI의 투자의견, λͺ©ν‘œΒ·μ†μ ˆκ°€, AIκ°€ μ°Έκ³ ν•œ 차트 νŒ¨ν„΄λ“€μ„ 확인할 수 μžˆμŠ΅λ‹ˆλ‹€.

Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A commo μ§€ν‘œλΆ„μ„

수읡λ₯  1μœ„ λ§€λ§€μ „λž΅μ€ Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A commo을 맀수 Β· 맀도 Β· 보유 Β· 관망 μ€‘μ΄μ—μš”.

멀버십 ν”Œλžœμ„ κ΅¬λ…ν•˜λ©΄ 수읡λ₯  1μœ„ λ§€λ§€μ „λž΅μ˜ λ§€λ§€ μ‹œμ μ„ ν™•μΈν•˜κ³  λ‹€μŒ μ‹ ν˜Έλ₯Ό μ•Œλ¦ΌμœΌλ‘œ λ°›μ•„λ³Ό 수 μžˆμŠ΅λ‹ˆλ‹€.

μ΅œμ‹  Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A commo κ΄€λ ¨ λ‰΄μŠ€

κ΄€λ ¨ λ‰΄μŠ€κ°€ μ—†μŠ΅λ‹ˆλ‹€.

Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A commo 맀좜 정보

ν•΄λ‹Ή μ’…λͺ©μ˜ 맀좜 정보가 μ—†μŠ΅λ‹ˆλ‹€.

μˆœλ§€μˆ˜λŸ‰

개인: -

κΈ°κ΄€: -

외인: -

λˆ„μ  μˆœλ§€μˆ˜λŸ‰

개인: -

κΈ°κ΄€: -

외인: -

순맀수

λ‚ μ§œ 개인 κΈ°κ΄€ 외인
μˆœλ§€μˆ˜λŸ‰ 정보가 μ—†μŠ΅λ‹ˆλ‹€.

λˆ„μ  순맀수

λ‚ μ§œ 개인 κΈ°κ΄€ 외인
λˆ„μ  μˆœλ§€μˆ˜λŸ‰ 정보가 μ—†μŠ΅λ‹ˆλ‹€.

Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A commo μžμ‚° λΉ„μœ¨

μžμ‚° λΉ„μœ¨ 정보가 μ—†μŠ΅λ‹ˆλ‹€.

Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A commo 맀좜 ꡬ성

맀좜 ꡬ성 정보가 μ—†μŠ΅λ‹ˆλ‹€.

Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A commo 곡맀도 ν˜„ν™©

곡맀도 ν˜„ν™© 정보가 μ—†μŠ΅λ‹ˆλ‹€.

Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A commo μ—…μ’… λ‚΄ 비ꡐ

μ—…μ’… λ‚΄ 비ꡐ 정보가 μ—†μŠ΅λ‹ˆλ‹€.